Inogen | INGN - Ebitda


Inogen reported $-9.42M in EBITDA for its fiscal quarter ending in September of 2023.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
Accuray USD -685K 900K Sep/2024
AngioDynamics USD 5.94M 3.78M Sep/2025
Artivion USD 22.72M 1.84M Dec/2025
AtriCure USD 27.28M 10.21M Jun/2026
Baxter International USD 309M 756M Mar/2026
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.63B 27M Jun/2026
Cooper Companies USD 323.4M 13.2M Dec/2025
Dexcom USD 364.5M 57.7M Mar/2026
Edwards Lifesciences USD 555.6M 485.5M Mar/2026
Globus Medical USD 231.83M 48.62M Mar/2026
Insulet USD 181.7M 12.3M Mar/2026
Medtronic USD 2.81B 119M Mar/2026
Orthofix International USD 27.88M 2.77M Dec/2025
Philips EUR 910M 343M Jun/2026
ResMed USD 547.48M 27.46M Dec/2025
Steris USD 394.7M 5M Dec/2025
Stryker USD 1.93B 357M Jun/2026
Tandem Diabetes Care USD 2.73M 30.17M Mar/2026
Teleflex USD 75.63M 171.44M Mar/2026
X T L Biopharmaceuticals USD -479K 19K Dec/2024
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025